Dr. Josep Genebriera De Lamo, MD

  • Maitland, FL
  • Dermatologist
NPI1548418346PAC ID2466599519
Medicare services, 2024
11,901
Medicare patients, 2024
1,931
Part D claims, 2024
3,408
Clinical trials
1
Hospital affiliations
1
Practice address
151 Southhall Ln, Maitland, FL 32751
Practice phone
Call (407) 333-4200
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Advanced Dermatology And Cosmetic Surgery

Dermatology practice · Maitland, Florida

Find Dr. Genebriera De Lamo's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Josep Genebriera De Lamo is a dermatologist in Maitland, Florida

Dr. Genebriera De Lamo practices at Advanced Dermatology And Cosmetic Surgery in Maitland, Florida.

Dr. Genebriera De Lamo's NPI, 1548418346, was assigned on September 4, 2008. Dr. Genebriera De Lamo holds Minnesota license 51915.

NPI and contact details
Medicare PAC ID
2466599519
NPI enumeration date
September 4, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(407) 333-4200
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Josep Genebriera De Lamo practices at Advanced Dermatology and Cosmetic Surgery in Maitland, Florida

Dr. Genebriera De Lamo's primary practice is Advanced Dermatology and Cosmetic Surgery, at 151 Southhall Ln, Maitland, FL 32751. The practice phone is (407) 333-4200.

  • Advanced Dermatology and Cosmetic Surgery
    151 Southhall Ln, Maitland, FL 32751Phone(407) 333-4200

Source: Dmand AI Affiliation Data

Dr. Josep Genebriera De Lamo is affiliated with 2 sites of care and 1 medical group

Dr. Genebriera De Lamo's primary practice is Advanced Dermatology And Cosmetic Surgery in Maitland, Florida. Dr. Genebriera De Lamo is also affiliated with UF Health Flagler Hospital. The medical group on file is Advanced Dermatology and Cosmetic Surgery.

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Josep Genebriera De Lamo's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Genebriera De Lamo practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Advanced Dermatology And Cosmetic SurgeryAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Genebriera De Lamo practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Josep Genebriera De Lamo is one of 1,200 dermatologists in Florida

Dermatology is Dr. Genebriera De Lamo's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Genebriera De Lamo is licensed in Minnesota.

Specialties and state licenses

  • Dermatology, MinnesotaPrimaryLicense 51915 · taxonomy 207N00000X

Dermatologists near Dr. Genebriera De Lamo

Counts of dermatologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Josep Genebriera De Lamo billed Medicare for 11,901 services in 2024

CMS data shows 11,901 Medicare services from Dr. Genebriera De Lamo across 28 procedure codes in 2024, for 1,931 Medicare patients. Medicare paid $515,770 for them. Every service was in an office.

Medicare services, 202411,901
Medicare patients1,931
Paid by Medicare$515,770
Procedure codes28

Dr. Genebriera De Lamo's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Surgery
2023: 9,2722024: 8,5698%
Office and hospital visits
2023: 3,2682024: 3,0357%
Drugs given in the office
2023: 2932024: 20929%
Tests and treatments
2023: 1112024: 8821%

Dr. Genebriera De Lamo compared with the Florida median for dermatologists, 2024

  • Dr. Genebriera De Lamo
  • Florida median
Medicare services
11,901vs 2,8664.2 times
Medicare patients
1,931vs 5703.4 times
Part D claims
3,223vs 5505.9 times

Medians across 1,138 dermatologists in Florida with Dmand AI profiles that report each measure.

Dr. Genebriera De Lamo's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Genebriera De Lamo

Need commercial claims for Dr. Genebriera De Lamo?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Genebriera De Lamo and other dermatologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Josep Genebriera De Lamo treated 1,931 Medicare patients in 2024, average age 75

CMS counts 1,931 Medicare patients who saw Dr. Genebriera De Lamo in 2024. The largest group is 65 to 74, with 877 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Genebriera De Lamo's median patient age at 73, with 49% women.

Medicare patients, 20241,931
Average age75
Average risk score1.07
Also on Medicaid3%

Dr. Genebriera De Lamo's Medicare patients by age, 2024

Dr. Genebriera De Lamo's Medicare patients by sex, 2024

  • Women88146%
  • Men1,05054%

Chronic conditions among Dr. Genebriera De Lamo's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis51%
  4. Ischemic heart disease33%
  5. Diabetes28%
  6. Chronic kidney disease23%
  7. Anxiety20%
  8. Mood disorders18%

Share of Medicare patients with each condition. A patient can have several.

Dr. Genebriera De Lamo's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women49%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Josep Genebriera De Lamo wrote 3,408 Medicare Part D claims in 2024

In 2024, Dr. Genebriera De Lamo wrote 3,408 Medicare Part D claims for 1,172 patients. 94% of them were for generic drugs. CMS names the drug for 3,223 of them, across 22 drugs with 11 or more claims each, at $611,868 in total drug cost. In 2023, CMS named 2,879 claims across 22 drugs.

Part D claims, 20243,408
Drugs named by CMS22
Total drug cost$611,868
Part D patients1,172

Dr. Genebriera De Lamo's Part D claims by kind of drug, 2024

  • Generic3,192 claims94%
  • Brand-name216 claims6%

Dr. Genebriera De Lamo's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Genebriera De Lamo's Part D claims, 2024

  • Antibiotics9%313 of 3,408 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2,8792024: 3,22312%

Drugs named by CMS: 22 in 2024, 22 in 2023.

See all prescribing by Dr. Genebriera De Lamo

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Josep Genebriera De Lamo ranks in the 99th percentile for removal of skin lesions in Medicare

Dr. Genebriera De Lamo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,737 procedures of removal of skin lesions by Dr. Genebriera De Lamo, more than 99% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Where Dr. Genebriera De Lamo ranks in Medicare procedure volume

Removal of skin lesions
99th percentile3,737 procedures
Skin biopsy
99th percentile1,548 procedures
Melanoma (skin cancer) excision
97th percentile207 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find dermatologists like Dr. Genebriera De Lamo by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Josep Genebriera De Lamo has worked on 1 clinical trial

Dmand AI links Dr. Genebriera De Lamo to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Genebriera De Lamo that name 1 trial.

Conditions in Dr. Genebriera De Lamo's trials

  • Psoriasis
  • Skin Diseases, Papulosquamous

Investigators on the most trials with Dr. Genebriera De Lamo

Recent clinical trials with Dr. Genebriera De Lamo

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Josep Genebriera De Lamo received $200,344 in industry payments from 2016 to 2025

CMS Open Payments shows 2,157 general payments to Dr. Genebriera De Lamo from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 76% of the total. Abbvie Inc. paid the most, $157,023. It also lists 1 research payment totaling $75 in 2016, naming 1 clinical trial.

General payments to Dr. Genebriera De Lamo by program year, 2016 to 2025

General payments to Dr. Genebriera De Lamo by kind, 2016 to 2025

$200.3Kin total
  • Speaker and faculty fees$152,42576%
  • Food and beverage$39,98020%
  • Travel and lodging$7,6204%
  • Education$3190%

Companies that paid Dr. Genebriera De Lamo the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Genebriera De Lamo

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Josep Genebriera De Lamo's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Josep Genebriera De Lamo

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Josep Genebriera De Lamo's NPI number?

Dr. Josep Genebriera De Lamo's NPI number is 1548418346. It was assigned on September 4, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Josep Genebriera De Lamo?

Dr. Josep Genebriera De Lamo is a dermatologist in Maitland, Florida. The primary specialty in the NPI Registry is Dermatology Physician (taxonomy code 207N00000X).

Where does Dr. Josep Genebriera De Lamo practice?

Dr. Genebriera De Lamo practices at 151 Southhall Ln, Maitland, FL 32751. Dr. Genebriera De Lamo's primary practice is Advanced Dermatology And Cosmetic Surgery in Maitland, Florida.

What is Dr. Josep Genebriera De Lamo's office phone number?

The practice phone on file for Dr. Genebriera De Lamo is (407) 333-4200.

What is Dr. Josep Genebriera De Lamo's medical license number?

Dr. Genebriera De Lamo holds Minnesota license 51915.

Which hospitals is Dr. Josep Genebriera De Lamo affiliated with?

Dr. Genebriera De Lamo is affiliated with UF Health Flagler Hospital.

What medical group is Dr. Josep Genebriera De Lamo part of?

Dr. Genebriera De Lamo is linked to Advanced Dermatology and Cosmetic Surgery.

Does Dr. Josep Genebriera De Lamo accept Medicare?

Yes. CMS data shows Dr. Genebriera De Lamo billed Medicare for 11,901 services in 2024, and Dr. Genebriera De Lamo accepts Medicare assignment.

How many Medicare patients does Dr. Josep Genebriera De Lamo see?

CMS counts 1,931 Medicare patients who saw Dr. Genebriera De Lamo in 2024, with an average age of 75.

What services does Dr. Josep Genebriera De Lamo bill to Medicare?

In 2024, Dr. Genebriera De Lamo's most billed Medicare services were surgery: skin and soft tissue (17003), office visit, established patient (99213) and surgery: skin and soft tissue (17000).

Show 4 more questionsShow fewer questions

What drugs does Dr. Josep Genebriera De Lamo prescribe most?

In 2024 Medicare Part D data, Dr. Genebriera De Lamo's most prescribed drugs by claims were Triamcinolone Acetonide, Ketoconazole and Hydrocortisone.

Has Dr. Josep Genebriera De Lamo received payments from drug or device companies?

CMS Open Payments shows $200,344 in general payments to Dr. Genebriera De Lamo from 44 companies from 2016 to 2025. The largest total came from Abbvie Inc.

How long has Dr. Josep Genebriera De Lamo been practicing?

Dr. Genebriera De Lamo graduated from medical school in 2002, 24 years ago.

Does Dr. Josep Genebriera De Lamo do research?

Dr. Genebriera De Lamo has worked on 1 clinical trial.

Selling to dermatology practices?

See dermatologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)